A THIN-FILM METAL ALLOY GRAFT
UCLA Technology Available For Licensing

BACKGROUND:  Surgical bypass operations reroute blood around clogged arteries and through an autologous or synthetic vascular graft. Autologous grafts are frequently obtained from the patient itself, using the saphenous vein or internal mammary artery. Synthetic vascular grafts can also be used and are usually made from Gore-Tex® or Dacron. Both autologous and synthetic grafts have drawbacks, however.

Since autologous grafts are harvested from the patient's own body, a separate surgery is required. This increases the likelihood for complications. Disadvantages associated with current synthetic grafts include thrombogenicity, poor elasticity, high inflammation rates and low compliance, all of which can lead to vessel re-closure. Furthermore, synthetic grafts have a minimum inner diameter of 6mm. This is often larger than desired, but is determined by the material. Thus there is a need for a vascular graft that can overcome the current limitations associated with autologous and synthetic grafts.

INNOVATION:  UCLA researchers have designed a thin film metal alloy vascular graft with potential use in various vascular diseases. The metal alloy is unique in that its inherent shape-memory property allows it to retain its original shape and integrity after physical manipulation. This could allow for the delivery of vascular grafts via a catheter.

Thin film metal alloys have demonstrated a clear advantage over Gore-Tex®-based implantable devices. They have proven to be non-toxic, biocompatible and non-thrombogenic. The investigators are looking to develop small diameter vascular grafts (<6mm) using the technology. Small diameter grafts would increase the number of applications in which grafts could be used.

POTENTIAL APPLICATIONS 

ADVANTAGES

Reference: UCLA Case No. 2005-600

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095-7231
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
NCD URL:   http://www.research.ucla.edu/tech/ucla05-600.htm

Lead Inventor: Daniel Levi

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/oipa/industry

Copyright © 2006 The Regents of the University of California.

keywords: active smart materials medical device uclancd ucla technologies intellectual property patents technology transfer invention business card